It represents another vaccine developed with a technology that allows, in addition to eliminating the possibility of mutations associated with virus propagation in eggs, a faster production speed with higher overall yield and the ability to negate the potential risk of egg albumin allergies in atopic individuals [34,55,56,57]. The gene discussed is ALB; the disease is allergic disease.